Posts Tagged ‘screening’

PROSTABLOG NZ: The NZ Listener magazine has commissioned an article on cancer and the theme will be screening.

I was interviewed for it today and I think the writer has a good grasp of the issues.

Look forward to seeing what she comes up with.

Does anyone know what happened to the NZ Parliamentary inquiry into prostate cancer?

It was supposed to get more evidence from the Ministry of Health in November, when the ministry expected to have completed its analysis of the two big randomised studies into PSA screening.

Read Full Post »

URO TODAY: Some 56,000 prostate cancer deaths were averted in the US over the 20 years following the introduction of PSA testing in 1985, say researchers writing in the online edition of the US Journal of the National Cancer Institute. READ MORE>

The authors estimate that in total, 1,305,600 US men were diagnosed with prostate cancer (CaP) between 1986 and 2005. They say 1,004,800 men were treated with surgery or radiation.

They conclude that 56,500 prostate cancer deaths have been averted and that 23 men had to be diagnosed and 18 treated for each man experiencing a benefit from screening, diagnosis and treatment.

CaP incidence rose about 12% per year after 1986 and peaked in 1992. It then declined at 10% per year for a three-year period.

Although incidence stabilised for the years 1995-2005, overall it increased 26% from 1986 to 2005.

However, for men over age 80 the incidence declined from 1986 to 2005, for men ages 70-79 it was stable, for men ages 60-69 it doubled, for men ages 50-59 it tripled and for men less than 50 years old it increased seven-fold.

Read Full Post »

new-zealand-parliamentJULY 20: PROSTABLOG NZ: New Zealanders have until August 21 to make submissions to the world’s only current parliamentary inquiry into prostate cancer screening.

Terms of reference for the inquiry by the Health Select Committee were announced today. The committee seeks:

1.      A summary of the contemporary literature on the subject including, incidence, mortality, groups at risk, testing options (with particular reference to age and family history, treatment and what other countries are doing).

2.    Opinions from –

  • affected and asymptomatic men, their families, patient advocacy groups including the Prostate Cancer Foundation and the National Screening Advisory Committee;
  • specialist clinicians, radiation oncologists, urologists and general practitioners;
  • epidemiologists, and those involved with the Ministry of Health, New Zealand Guidelines Group.

3.    Best methods to promote awareness for early detection and treatment of prostate cancer.

4.    A cost benefit analysis, if appropriate.


Read Full Post »